Eli Lilly, Corning, Dominion, Dave & Buster's and Etsy Move on Analyst Calls and Earnings

According to CNBC, Eli Lilly was upgraded to buy from hold at Berenberg, which set a $1,400 price target and said the drugmaker should keep its lead in obesity treatments. The firm also said the market is underestimating Lilly's acquisition strategy and the multibillion-dollar sales potential of assets beyond obesity. Corning was kept at buy by Mizuho, but the price target was cut to $180 from $210 after the company announced a $2 billion stock sale. Dominion and NextEra also raised the consumer benefits tied to their planned $67 billion merger, offering residential customers a $10 monthly bill credit for four years, up from an earlier two-year proposal. Dave & Buster's fell more than 13% in premarket trading after missing on both revenue and earnings, while same-store sales declined 2.9%, better than the 3.4% drop that had been feared. Etsy was upgraded to buy from hold at Oppenheimer, which set a $90 price target and said consumer survey results point to improving products and reduced reliance on Google through AI search.